Novel Agent Shows Promise in Bronchiectasis Novel Agent Shows Promise in Bronchiectasis

Brensocatib, a small-molecule DPP1 inhibitor, could be a good nonantibiotic option for reducing exacerbations in patients with bronchiectasis, new research shows.Medscape Medical News

Source: Medscape Medical News Headlines - July 8, 2020 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news